Distribution of AB0 and Rh blood groups in cancer patients; is A Rh (+) blood group a risk factor in colorectal cancer development?

Muhammed Gömeç; Hüseyin Özden

doi:10.7197/cmj.950194

EN

Distribution of AB0 and Rh blood groups in cancer patients; is A Rh (+) blood group a risk factor in colorectal cancer development?

Abstract

Objective: Genetic factors have been the subject of many studies in cancer etiology. One of the most striking of these is the relationship between blood groups and cancer. Therefore, in our study, we examined the relationship between blood groups of stomach, colorectal, breast, thyroid and pancreatic cancers, which are common in general surgery practice, with single-center data.

Method: We retrospectively analyzed cancer cases who applied to our University Hospital between 2005-2021. This analysis was done using a hospital database. 7899 cancer patients were included in the study. Cancer types, blood types, ages and gender of the patients were recorded. Results were analyzed statistically.

Results: 55.2% of the patients included in the study were male and 42.8% were female. Of the patients, 553 (7%) were stomach, 767 (9.7%) colorectal, 779 (9.9%) breast, 625 (55.15%) thyroid, 209 (2.6% ) pancreatic cancer. 87.4% of the patients were Rh (+), 12.6% of them were Rh (-). 38% of patients A Rh (+), 5.2% A Rh (-), 13.8% B Rh (+), 2.2% B Rh (-), 7.7% AB Rh (+), 1.3% AB Rh (-), 28% 0 Rh (+), 3.8% 0 Rh (-). With the blood group distribution of all cancers; When the blood group distribution of gastric, colorectal, breast, thyroid and pancreatic cancers were compared, no statistically significant difference was found. However, it was found that the A Rh (+) blood group was higher in colorectal cancers compared to other cancers.

Conclusions: In our study, no relationship was found between all cancers and blood type. In addition, no relationship was found between blood type and stomach, colorectal, breast, thyroid and pancreatic cancers, which are common in general surgery practice. Although it is generally accepted that especially A blood group is a risk factor for gastric cancer, there was no significant difference in our patient series. When AB0 and Rh blood groups were evaluated together, the A Rh (+) blood group was seen more in colorectal cancers.

Keywords

Kaynakça

1. Storry J, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology. 2009;25(2):48.
2. Siransy LK, Nanga ZY, Zaba FS, Tufa NY, Dasse SR. ABO/Rh blood groups and risk of HIV infection and Hepatitis B among blood donors of Abidjan, Côte D’ivoire. European Journal of Microbiology and Immunology. 2015;5(3):205-209.
3. Farhud DD, Yeganeh MZ. A brief history of human blood groups. Iranian Journal of Public Health. 2013;42(1):1-6.
4. Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfusion. 2016;14(5):434.
5. Mao Y, Yang W, Qi Q, et al. Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review. BMC cancer. 2019;19(1):1-9.
6. Wolpin BM, Chan AT, Hartge P, et al. ABO Blood Group and the Risk of Pancreatic Cancer. JNCI: Journal of the National Cancer Institute. 2009;101(6):424-431.
7. Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB. ABO blood group and cancer. European Journal of Cancer. 2010;46(18):3345-3350.
8. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM. ABO blood group and breast cancer incidence and survival. International Journal of Cancer. 2012;130(9):2129-2137.

9. Anstee D. The relationship between blood groups and disease. Blood. 2010;115(23):4635-4643.
10. Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood transfusion. 2013;11(4):491.
11. Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. Journal of thrombosis and thrombolysis. 2014;38(2):160-166.
12. Franchini M, Lippi G. The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer. BMC medicine. 2015;13(1):1-3.
13. Schwarz HP, Dorner F. Karl Landsteiner and his major contributions to haematology. British journal of haematology. 2003;121(4):556-565.
14. Tan SY, Graham C. Karl Landsteiner (1868-1943): originator of ABO blood classification. Singapore Med J. 2013;54(5):243-244.
15. Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018). CA-A CANCER JOURNAL FOR CLINICIANS. 2020;70(4):313-313.
16. Edgren G, Hjalgrim H, Rostgaard K, et al. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. American journal of epidemiology. 2010;172(11):1280-1285.
17. Huang JY, Wang R, Gao Y-T, Yuan J-M. ABO blood type and the risk of cancer–Findings from the Shanghai Cohort Study. PloS one. 2017;12(9):e0184295.
18. Akin S, Altundag K. Clinical associations with abo blood group and rhesus blood group status in patients with breast cancer: a nationwide retrospective study of 3,944 breast cancer patients in Turkey. Medical science monitor: international medical journal of experimental and clinical research. 2018;24:4698.
19. Luzón-Toro B, Fernández RM, Villalba-Benito L, Torroglosa A, Antiñolo G, Borrego S. Influencers on thyroid cancer onset: molecular genetic basis. Genes. 2019;10(11):913.
20. Tam AA, Özdemir D, Fakı S, Bilginer MC, Ersoy R, Çakır B. ABO Blood Groups, Rh Factor, and Thyroid Cancer Risk: To ‘B’or Not to ‘B’. Endocrine research. 2020;45(2):137-146.
21. Tanaka Y, Kumagi T, Terao T, et al. ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. Internal Medicine. 2020;59(6):761-768.
22. Aktaş A, Gamze Ü. Evaluation of the distribution of ABO and Rh blood groups in Sivas province. Cumhuriyet Medical Journal.43(1):55-61.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yazarlar

Muhammed Gömeç ^*
0000-0002-9127-3201
Türkiye

Hüseyin Özden
0000-0002-2786-3805
Türkiye

Yayımlanma Tarihi

1 Temmuz 2021

Gönderilme Tarihi

9 Haziran 2021

Kabul Tarihi

29 Haziran 2021

Yayımlandığı Sayı

Yıl 2021 Cilt: 43 Sayı: 2

DOI

https://doi.org/10.7197/cmj.950194

IZ

https://izlik.org/JA26BP92GN

Kaynak Göster

RIS / Bibtex

AMA

1.Gömeç M, Özden H. Distribution of AB0 and Rh blood groups in cancer patients; is A Rh (+) blood group a risk factor in colorectal cancer development? CMJ. 2021;43(2):182-188. doi:10.7197/cmj.950194

Cited By

A Surgeon's Endoscopy Experience

Turkish Journal of Science and Health

https://doi.org/10.51972/tfsd.1062352

Evaluation of the Association of Blood Group Type with Tumor Location, Polyp Type, and Colorectal Cancer Risk: A Case-control Study

International Journal of Cancer Management

https://doi.org/10.5812/ijcm-136225